Needham Maintains Buy on I-MAB, Lowers Price Target to $6
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Gil Blum maintains a Buy rating on I-MAB (NASDAQ:IMAB) but lowers the price target from $8 to $6.
March 15, 2024 | 1:28 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Needham maintains a Buy rating on I-MAB but lowers the price target from $8 to $6.
While the maintenance of a Buy rating by Needham indicates continued confidence in I-MAB's potential, the reduction in the price target from $8 to $6 could signal concerns about near-term challenges or valuation adjustments. This mixed signal might lead to neutral short-term price movement as investors weigh the positive endorsement against the lowered expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100